Osteopore (ASX:OSX) secured European Union Medical Device Regulation (EU MDR) approval for its custom orthopedic and cranial implants, according to a Wednesday filing with the Australian bourse.
The approval and the distribution deal with US medical device company Zimmer Biomet allow the company to supply the custom implants to the European market, the filing said.
Osteopore shares surged 200% in afternoon trade Wednesday.